The global contract research organization will invest $63.7 million to expand its bioanalytical lab in Henrico County, VA. Pharmaceutical Product Development, LLC (PPD), a global contract research ...

PPD is committed to employee development and engagement in the company culture of excellence in the enterprise of improving health. By deploying innovative initiatives to recruit, retain and develop ...

"I was working in Big Pharma," Fred Eshelman recalled, "and I looked at what we were paying consultants against what we were putting in our coffers. And I said to myself, 'Something's wrong with this ...

PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, ...

WILMINGTON, N.C.--Pharmaceutical Product Development, LLC (PPD) today announced it has strengthened its central laboratory testing services in infectious diseases, one of the largest therapeutic areas ...

LONDON and AUSTIN, Texas, July 16, 2019 /PRNewswire/ -- Leading companies in the life sciences and pharmaceutical industries such as Celgene, Merck KGaA, Pfizer, and Pharmaceutical Product Development ...

WILMINGTON – A business unit of Wilmington-based global contract research organization, Pharmaceutical Product Development (PPD), is expanding its global footprint. Accelerated Enrollment Solutions ...

Major CRO player Pharmaceutical Product Development (PPD) is set to go back on the public markets after announcing its IPO plans. The CRO went private all the way back in 2011 when it was bought by ...

No articles found. Pharmaceutical Product Development, LLC (PPD) did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

WILMINGTON – Life science conglomerate Pharmaceutical Product Development (PPD), which is based in Wilmington and has a large presence in Research Triangle Park, is going public today. The company ...

(Reuters) - Carlyle Group and Hellman & Friedman agreed to buy contract research company Pharmaceutical Product Development Inc for $3.9 billion in cash, in one of the largest leveraged buyouts of the ...

WILMINGTON, N.C. (WECT) - PPD is now a publicly traded company. PPD CEO David Simmons rang the Nasdaq opening bell Friday as the company began trading as a public company. It’s an exciting day in ...